title: Molecular cloning, sequence analysis and homology modeling of galE encoding UDP-galactose 4-epimerase of Aeromonas hydrophila.
abstract: A. hydrophila, a ubiquitous gram-negative bacterium present in aquatic environments, has been implicated in illness in humans, fish and amphibians. Lipopolysaccharides (LPS), a surface component of the outer membrane, are one of the main virulent factors of gram-negative bacteria. UDP-galactose 4-epimerase (GalE) catalyses the last step in the Leloir pathway of galactose metabolism and provides precursor for the biosynthesis of extracellular LPS and capsule. Due to its key role in LPS biosynthesis, it is a potential drug target. The present study describes cloning, sequence analysis and prediction of three dimensional structure of the deduced amino acid sequence of the galE of A. hydrophila AH17. The cloned galE consists of the putative promoter-operator region, and an open reading frame of 338 amino acid residues. Sequence alignment and predicted 3Dstructure revealed that the GalE of A. hydrophila consists of the signature sequences of the epimerase super family. The present study reports the molecular modeling / 3D-structure prediction of GalE of A. hydrophila. Further, the potential regions of the enzyme that can be targeted for drug design are identified.
authors.affiliation: Gene Regulation Laboratory, School of Biotechnology, Jawaharlal Nehru University, New Delhi - 110067, India.
authors.forename: Shivani
authors.initials: S
authors.lastname: Agarwal
authors.forename: Keshav
authors.initials: K
authors.lastname: Gopal
authors.forename: Gagan
authors.initials: G
authors.lastname: Chhabra
authors.forename: Aparna
authors.initials: A
authors.lastname: Dixit
references.citation: Infect Immun. 1996 Mar;64(3):855-60
references.pmid: 8641792
references.citation: J Infect Dis. 1975 May;131(5):553-8
references.pmid: 1092768
references.citation: Infect Immun. 2001 Jan;69(1):435-45
references.pmid: 11119535
references.citation: J Mol Graph. 1990 Mar;8(1):52-6, 29
references.pmid: 2268628
references.citation: Clin Infect Dis. 1998 Aug;27(2):332-44
references.pmid: 9709884
references.citation: J Bacteriol. 1996 Oct;178(20):5916-24
references.pmid: 8830687
references.citation: Can J Vet Res. 1986 Apr;50(2):165-73
references.pmid: 3530414
references.citation: Biochemistry. 1997 Sep 2;36(35):10675-84
references.pmid: 9271498
references.citation: Infect Immun. 2000 May;68(5):2594-601
references.pmid: 10768949
references.citation: Nucleic Acids Res. 1994 Nov 11;22(22):4673-80
references.pmid: 7984417
references.citation: Clin Microbiol Rev. 1991 Oct;4(4):397-410
references.pmid: 1747858
references.citation: Methods Enzymol. 1997;277:396-404
references.pmid: 9379925
references.citation: Adv Protein Chem. 1968;23:283-438
references.pmid: 4882249
references.citation: J Bacteriol. 2007 Jan;189(2):540-50
references.pmid: 17098903
references.citation: Curr Microbiol. 1998 Aug;37(2):144-8
references.pmid: 9662617
references.citation: Infect Immun. 2006 Jan;74(1):537-48
references.pmid: 16369010
references.citation: Nucleic Acids Res. 2003 Jul 1;31(13):3381-5
references.pmid: 12824332
references.citation: Microb Pathog. 1996 Jun;20(6):325-33
references.pmid: 8831828
references.citation: Biochemistry. 2000 May 16;39(19):5691-701
references.pmid: 10801319
references.citation: J Bacteriol. 1990 Aug;172(8):4392-8
references.pmid: 2198256
references.citation: J Biol Chem. 2003 Nov 7;278(45):43885-8
references.pmid: 12923184
references.citation: Infect Immun. 2002 May;70(5):2326-35
references.pmid: 11953367
references.citation: DNA Seq. 2007 Aug;18(4):302-6
references.pmid: 17541836
references.citation: J Biol Chem. 2001 May 4;276(18):15131-6
references.pmid: 11279032